German regulator concludes audit of Dr Reddy’s Vishakapatnam facility

12 Nov 2018 Evaluate

The Regulatory Authority of Germany (Regierung von Oberbayern) has concluded the follow-on audit of Dr. Reddy’s Laboratories’ Formulations manufacturing facility in Duvvada, Vishakapatnam, on November 09, 2018. The facility is considered compliant and the EU-GMP certification continues to remain active with one specific exclusion of a new product. The company will be submitting a detailed Corrective and Preventive Action Plan (CAPA) to the authorities.

Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Lab Share Price

1218.40 9.95 (0.82%)
30-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1595.00
Dr. Reddys Lab 1218.40
Cipla 1323.95
Zydus Lifesciences 885.20
Lupin 2151.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×